Neville Rodie & Shaw’s Pfizer PFE Stock Holding History

Neville Rodie & Shaw’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.56M	Hold	64,658	–	–	0.1%	108
2026 Q1	$1.81M	Hold	64,658	–	–	0.13%	96
2025 Q4	$1.61M	Sell	64,658 -17,676	-21%	-$446K	0.11%	103
2025 Q3	$2.1M	Sell	82,334 -1,126	-1%	-$27.8K	0.15%	89
2025 Q2	$2.02M	Sell	83,460 -18,864	-18%	-$440K	0.15%	89
2025 Q1	$2.59M	Sell	102,324 -2,404	-2%	-$62.9K	0.2%	79
2024 Q4	$2.78M	Buy	104,728 +8,365	+9%	+$227K	0.2%	82
2024 Q3	$2.79M	Sell	96,363 -200	-0.2%	-$5.83K	0.21%	78
2024 Q2	$2.7M	Sell	96,563 -42,898	-31%	-$1.18M	0.21%	78
2024 Q1	$3.87M	Sell	139,461 -9,381	-6%	-$260K	0.3%	69
2023 Q4	$4.29M	Sell	148,842 -6,921	-4%	-$209K	0.35%	61
2023 Q3	$5.17M	Sell	155,763 -252	-0.2%	-$8.91K	0.46%	52
2023 Q2	$5.72M	Sell	156,015 -1,515	-1%	-$59K	0.49%	52
2023 Q1	$6.43M	Buy	157,530 +2,714	+2%	+$117K	0.58%	46
2022 Q4	$7.93M	Buy	154,816 +7,000	+5%	+$336K	0.75%	38
2022 Q3	$6.47M	Sell	147,816 -8,897	-6%	-$432K	0.64%	46
2022 Q2	$8.22M	Hold	156,713	–	–	0.74%	43
2022 Q1	$8.08M	Hold	156,713	–	–	0.6%	47
2021 Q4	$9.25M	Sell	156,713 -2,172	-1%	-$108K	0.66%	43
2021 Q3	$6.83M	Sell	158,885 -646	-0.4%	-$28.6K	0.53%	49
2021 Q2	$6.25M	Buy	159,531 +166	+0.1%	+$6.46K	0.48%	54
2021 Q1	$5.77M	Buy	159,365 +5,100	+3%	+$181K	0.48%	55
2020 Q4	$5.68M	Sell	154,265 -8,778	-5%	-$322K	0.49%	54
2020 Q3	$5.68M	Sell	163,043 -1,160	-0.7%	-$40.7K	0.54%	50
2020 Q2	$5.09M	Sell	164,203 -1,017	-0.6%	-$34.6K	0.53%	54
2020 Q1	$5.12M	Sell	165,220 -7,541	-4%	-$257K	0.62%	52
2019 Q4	$6.42M	Sell	172,761 -10,013	-5%	-$357K	0.63%	48
2019 Q3	$6.23M	Sell	182,774 -9,564	-5%	-$348K	0.66%	51
2019 Q2	$7.91M	Sell	192,338 -2,372	-1%	-$94.2K	0.84%	37
2019 Q1	$7.85M	Sell	194,710 -4,230	-2%	-$169K	0.83%	36
2018 Q4	$8.24M	Buy	198,940 +132	+0.1%	+$5.48K	1%	29
2018 Q3	$8.31M	Sell	198,808 -6,086	-3%	-$234K	0.82%	42
2018 Q2	$7.05M	Sell	204,894 -1,054	-0.5%	-$36K	0.74%	48
2018 Q1	$6.93M	Sell	205,948 -669	-0.3%	-$23K	0.76%	47
2017 Q4	$7.1M	Buy	206,617 +1,002	+0.5%	+$34.2K	0.75%	49
2017 Q3	$6.96M	Sell	205,615 -1,476	-0.7%	-$47.4K	0.78%	48
2017 Q2	$6.6M	Sell	207,091 -1,397	-0.7%	-$44.1K	0.75%	49
2017 Q1	$6.77M	Sell	208,488 -3,836	-2%	-$121K	0.77%	42
2016 Q4	$6.54M	Sell	212,324 -7,779	-4%	-$237K	0.77%	41
2016 Q3	$7.07M	Buy	220,103 +1,160	+0.5%	+$38.8K	0.83%	36
2016 Q2	$7.31M	Sell	218,943 -1,276	-0.6%	-$40.7K	0.88%	34
2016 Q1	$6.19M	Sell	220,219 -73	-0%	-$2.08K	0.75%	48
2015 Q4	$6.75M	Buy	220,292 +23,935	+12%	+$753K	0.81%	37
2015 Q3	$5.85M	Sell	196,357 -2,348	-1%	-$75.3K	0.72%	47
2015 Q2	$6.32M	Sell	198,705 -1,845	-0.9%	-$60.1K	0.69%	45
2015 Q1	$6.62M	Buy	200,550 +53	+0%	+$1.69K	0.69%	44
2014 Q4	$5.92M	Sell	200,497 -4,235	-2%	-$121K	0.6%	53
2014 Q3	$5.74M	Buy	204,732 +16,358	+9%	+$459K	0.57%	53
2014 Q2	$5.3M	Sell	188,374 -1,320	-0.7%	-$37.6K	0.53%	55
2014 Q1	$5.78M	Sell	189,694 -332	-0.2%	-$9.9K	0.63%	46
2013 Q4	$5.52M	Sell	190,026 -11,225	-6%	-$327K	0.6%	49
2013 Q3	$5.49M	Sell	201,251 -8,537	-4%	-$232K	0.64%	48
2013 Q2	$5.58M	Buy	+209,788	New	+$5.8M	0.67%	45

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Neville Rodie & Shaw's PFE Position: Q2 2026 in Review

Neville Rodie & Shaw held its Pfizer (PFE) position steady in Q2 2026 at 64,658 shares worth $1.56M. The position accounts for 0.1% of the portfolio, ranked #108.

Neville Rodie & Shaw first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.25M in Q4 2021. 1,102 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Neville Rodie & Shaw held 64,658 shares of Pfizer worth $1.56M as of Q2 2026.
Neville Rodie & Shaw left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.1% of Neville Rodie & Shaw's portfolio in Q2 2026, its #108 holding.
Neville Rodie & Shaw first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Neville Rodie & Shaw's Pfizer position peaked at $9.25M in Q4 2021.
1,102 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Neville Rodie & Shaw's 13F filing for Q2 2026, filed 6 Jul 2026.